摘要
Technologies for diabetes management,such as continuous subcutaneous insulin infusion(CSII)and continuous glucose monitoring(CGM)systems,have improved remarkably over the last decades.These developments are impacting the capacity to achieve recommended hemoglobin A1c levels and assisting in preventing the development and progression of microand macro vascular complications.While improvements in metabolic control and decreases in risk of severe and moderate hypoglycemia have been described with use of these technologies,large epidemiological international studies show that many patients are still unable to meet their glycemic goals,even when these technologies are used.This editorial will review the impact of technology on glycemic control,hypoglycemia and quality of life in children and youth with type 1 diabetes.Technologies reviewed include CSII,CGM systems and sensoraugmented insulin pumps.In addition,the usefulness of advanced functions such as bolus profiles,bolus calculators and threshold-suspend features will be also discussed.Moreover,the current editorial will explore the challenges of using these technologies.Indeed,despite the evidence currently available of the potential benefits of using advanced technologies in diabetes management,many patients still report barriers to using them.Finally this article will highlight the importance of future studies tailored toward overcome these barriers to optimizing glycemic control and avoiding severe hypoglycemia.
Technologies for diabetes management, such ascontinuous subcutaneous insulin infusion （CSII） andcontinuous glucose monitoring （CGM） systems, haveimproved remarkably over the last decades. Thesedevelopments are impacting the capacity to achieverecommended hemoglobin A1c levels and assisting inpreventing the development and progression of microandmacro vascular complications. While improvementsin metabolic control and decreases in risk of severe andmoderate hypoglycemia have been described with useof these technologies, large epidemiological internationalstudies show that many patients are still unable to meettheir glycemic goals, even when these technologies areused. This editorial will review the impact of technologyon glycemic control, hypoglycemia and quality of life inchildren and youth with type 1 diabetes. Technologiesreviewed include CSII, CGM systems and sensoraugmentedinsulin pumps. In addition, the usefulnessof advanced functions such as bolus profiles, bolus calculatorsand threshold-suspend features will be alsodiscussed. Moreover, the current editorial will explore thechallenges of using these technologies. Indeed, despitethe evidence currently available of the potential benefitsof using advanced technologies in diabetes management,many patients still report barriers to using them. Finallythis article will highlight the importance of future studiestailored toward overcome these barriers to optimizingglycemic control and avoiding severe hypoglycemia.
